Drug Trial Radar · NCT07908381
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
860
Planned (sponsor's estimate)
Start
Oct 19, 2026
Primary completion
Jul 2029
Study completion Jul 2029
Sponsor
- Lead sponsor
- Enanta Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- First posted
- Nov 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Zelicapavir is a novel orally administered non-fusion replication inhibitor of RSV that is being developed for the treatment of patients with RSV infection. This phase 2b/3 study will evaluate the efficacy and safety of zelicapavir compared with placebo in adults with RSV who are at high risk for severe disease. High-risk participants include those who are either ≥75 years of age or ≥18 years of age with COPD and/or CHF. Participants will be non-hospitalized adults who have up to 72 hours of respiratory tract infection symptoms and test positive for RSV.
Conditions
- RSV
Interventions
zelicapavirDrug
Zelicapavir 800mg, once daily for 7 days
PlaceboDrug
Participants will take matching placebo, once daily for 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to complete resolution of all 13 RSV symptoms as assessed by the Respiratory Infection Intensity and Impact Questionnaire (RiiQ) symptom scaleTime frame: Day 1 through Day 21
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
C&A Clinical Trials Corp
Cape Coral, Florida · Recruiting
Continental Clinical Research, LLC
Miami, Florida · Recruiting
PanAmerican Clinical Research
Bluffton, South Carolina · Recruiting
PanAmerican Clinical Research - Brownville
Brownsville, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.